Pharmaceutical industries should apply rigorous QC (quality control) to ensure the consistency, safety, and efficacy of their herbal derived drug-preparations. QC must be performed at every stage of the production line i.e. incoming raw materials, extractions, in-process control, finished products and keeping samples. Due to the complex nature of the chemical content of herbal drugs, two approaches to QC should be taken, that is quantitative determination of the selected marker(s) compound(s), and metabolite profiling. Contamination of herbal medicines by heavy metals, pesticides, toxic metabolites, microbial toxins, pathogenic microorganisms and other foreign matter should also be evaluated. A combination of chemical profiling and multivariate analysis (MVA) is recommended as the QC tool for the botanical identification method (BIM) of herbs, extracts, herb materials, and herbal drug preparations. Microscopic methods, DNA profiling or chemical marker(s) are not recommended for use as the sole BIM due to the lack of specificity. Only markers that meet certain criteria i.e. quality active (QA) markers can be utilized as a QC tool. The limit specification range of markers used as QC tools should be described in the analytical target profile (ATP). To gain reliable results of any analysis that has been performed at any QC laboratory, the analysis method must be validated according to the newest guidance. Sample detection limit of any toxic compound(s) should be lower than its cut-off value and MPL. The reliability of any results of analysis of a QC laboratory must be evaluated by using QC-samples for each series of measurements.
Herbal derived drug preparations or herbal medicines have been used worldwide for centuries. Herbal medicines can contain single or multiple herbs in a single drug preparation. That is why herbal medicines could have a complex mixture of many herbs that contain many chemical compounds [1, 2] . According to the WHO guidelines [3] herbal medicines are herbs, herbal materials, herbal preparations and finished herbal products. Herbs include crude materials that can derive from lichen, fungi, algae and parts of higher plant materials, which may be entire, fragmented or powdered, whilst herbal materials include fresh juices, gums, fixed oils, essential oils, resins and dry powders of herbs. These materials may be processed by steaming, roasting, backing with honey or alcoholic beverages. Herbal preparations may include comminuted or cut herbal materials, or extracts, tinctures and fatty oils of herbal materials. Finished herbal products and mixtures of herbal products may contain excipients in addition to the active ingredients i.e. herbal preparations made from one or more herbs or their extracts. If more than one herb is used, the term "mixture herbal product" was used. The term "Botanical" of FDA [4] means products that include plant materials, algae, macroscopic fungi, and combinations thereof; it does not include products that contain animals or animal parts, GMO plants, products produced by fermentation of yeast, bacteria, plant cells, or other microscopic organisms, and highly purified compounds either derived from nature or chemically modified. Products that contain chemically defined isolated constituents, or a mixture thereof, are not herbal medicine products [5] . Botanicals can be available as two different products i.e. herbal medicinal products or as plant food supplements (PFS) [6] .
In Indonesia, herbal medicines were generally called Obat tradisional, and comprised: (1) non standardized traditional drugs (Jamu), (2) standardized herbal drugs (Obat Herbal Terstandard or OHT). This meant herbal drugs that had their safety and efficacy already proved by pre-clinical studies, and (3) Phytopharmaceuticals (Fitofarmasi), that could be defined as (2) with additional clinical studies. Nowadays, herbal medicines in Indonesia are produced by many pharmaceutical companies, and according to the BPOM (Indonesian National Agency of Drug and Food Control), 872 companies were registered in 2005; the growth rate of these products in Indonesia was estimated at 20-30% annually [7, 8] .
Due to the increasing application of herbal medicines or herbal drugs globally, also in Indonesia, in the last decade, QC of the drug preparations derived from herbs is very important. This QC can be used to monitor their efficacy and toxicity [1, 9, 10] . QC should be performed at all stages of the production line of the herbal derived products i.e. incoming raw materials (herbs, herbal materials, extracts, excipients), in-process control (IPC), finished products (FP) and keeping samples (KS) of FP ( Figure 1 ).General guidelines for evaluating the quality of herbs and herbal derived drugs have been issued by many countries and organizations e.g. EMA [5, 11] , FDA [4] , AOAC [12] , WHO [13] , USP Herbal Medicine Compendium [14] , Hong Kong Chinese Materia Medical Standard [15] , Farmakope Herbal Indonesia (Indonesian Herbal Pharmacopoeia) [16] , American Herbal Products Association [17] , and British Pharmacopoeia (BP) 2018 [18] . Unfortunately the described official methods are very general, and only have specific application for certain herbs or herb materials. It seems the described methods could not be applied directly for analyzing mixtures of herbals in the product preparations. A specific method of analysis, as the QC tool, should be self-developed and validated by the pharmaceutical companies for each of their herbal product preparations.
Some interesting review articles on QC methods for herbal drugs have been published. Jiang et al. in 2010 [19] Indrayanto an integration process analytical technology of herbal drugs from raw materials to finished extracts or active ingredients using a combination of spectroscopy methods and multivariate analysis (MVA). General analytical validation methods for the analysis of botanical drugs were reviewed and discussed by Brown and Lister [22] , whilst validation chromatographic methods of analyses for specific applications for herbal medicines were reviewed recently by the author [23] , proposed a holistic strategy for quality and safety control for traditional Chinese medicines [24] . Abdel-Tawab described very general method assessments for botanicals as PFS products [6] .
In the last three years some important new developments in QC methods for herbal medicines have been published: (1) new descriptions of markers as QC tools, and the methods of determination; (2) application of chemical profiles for the determination of certain herbs in herbal medicines, qualitatively and quantitatively; (3) determination of sample detection limit and its verification; and (4) newer statistical techniques of validation methods. Unfortunately, those new aspects were not discussed in detail in the previously described reviews [6, [19] [20] [21] [22] [23] [24] . This present article will discuss these new aspects and other recent developments that could be applied, and be useful as QC tools for the pharmaceutical industry.
Sampling methods in manufacturing processes of herbal drugs:
Sampling is the most essential part of QC in the pharmaceutical industry; if the samples are not representative, the whole QC processes is useless. USP <561> [25] has been described as the sampling method for samples of botanical origin or herbs. All containers must be sampledif the number of containers (n) = 1-10; 11 containers if n = 11-19; if n containers> 19, the number of containers to be sampled is 10 + n/10. Samples must be taken from upper, middle and lower sections of the container. If the plant materials consist of parts < 1 cm or less or powdered materials, a sampling device can be used; if samples have parts > 1 cm, samples can be withdrawn by hand. For containers with < 1 kg materials, after mixing, sufficient quantity of samples can taken out; for containers 1-5 kg, a sample must be withdrawn from upper, middle and lower parts; if container is > 5 kg, 250 g samples must be withdrawn from upper, middle and lower parts, and after mixing, a portion taken for testing. WHO [13] recommended a procedure for sampling of herbs as follows: for containers or packaging n= 5, all must be sampled; n = 6-50, a sample should be taken from each of five containers; n >50, take 10% for sample, rounding up the number of units to the nearest multiple of 10, e.g. if n = 52 this would be sampled as n = 60. General sampling methods that have been explained in detail in USP 41 <1010> [26] can be applied for samples at each stage of the production line in the manufacturing processes of herbal derived drugs in the pharmaceutical industry; in this case, a random sampling method is usually recommended.
Chemical profiling method as QC tool for herbal medicines:
Confirming the identity of the incoming herbs or extracts is a crucial step in producing good quality products for herbal medicines (Figure 1 ). General methods for identification of plant materials or herbs by using macroscopic-, microscopic-, and chromatographicmethods are described officially e.g. by WHO [13] , USP Herbal Medicines Compendium [14] , Indonesian Herbal Pharmacopeia [16] , American Herbal Product Association [17] , BP 2018 [18] and USP 41 <563> [27] . Our experiences showed that the application of only macroscopic-and microscopic-methods for identification of commercial herbs or herbal materials could not be utilized, due to the lack of specificity, and so additional chemical-and/or DNAprofiling methods of identification needed to be performed. These macroscopic-and microscopic-methods are characteristic, but not specific. TLC methods for identification of articles of botanical origin are explained by USP 41 <203> [28] , and <1064> [29] . Evaluation of the HPTLC methods were performed by comparing visually the chromatograms of samples and authentic botanical reference material (BRM); the sequences of zones (spots) that have specific positions (R f ), colors and intensity (TLC profiles or finger printings) are evaluated and compared. Evaluation of TLC/HPLC chromatograms by visual means only (i.e. comparing R f , R t , peak intensity and color), as described in some guidance as shown above, could be very subjective and difficult. Identical R f /R t , colors and intensities of two spots/peaks does not mean identical compounds. That is why it is recommended to evaluate the chromatograms (HPLC/TLC) by using a DAD detector or a TLC-scanner (densitometry). Using these, the identity and purity of the target peak(s) could be evaluated by comparison with an authentic standard. Evaluation of TLC-spots can also be performed by using a video-densitometric method, but unfortunately, in this method, the identity and purity of the peaks cannot be evaluated. Recently Frommenwiller et al. [30] applied peak profiles (PPI) directly from the finger printing images of the TLC spots for evaluating samples of Angelica gigas root. For confirming the chemical structure of the target spot/peak of the TLC [31] or HPLC unambiguously, the chromatographic system must be coupled with a MS detector. . The main disadvantage of applying chromatographic methods is that they are time consuming; this is due to various reasons i.e. samples must be extracted with a selected solvent, the stability of the sample in this selected solvent must be evaluated, and all target peaks must be evaluated regarding their identity and purity [23] . To solve this problem, the application of direct methods (MS, FT-IR, NIR, and Raman) for identification of herbal materials and extracts in drug preparations could be preferred and very interesting. Some recent publications reported the application of direct MS combined with multivariate analysis (MVA) for identifying herbal powdered materials, their adulterants and related herbs [32] [33] [34] . It seemed that direct MS identification of plants or herbs was more specific compared with DNA profiling, especially for closely related herbal species [35, 36] . The drawback of the application of LC-MS/MS-or direct MS-profiling is the relatively high price of the equipment and its operation cost; not many pharmaceutical companies have utilized this equipment. The application of ATR-FT-IR methods were preferred for direct identification and quantitative estimation of herbs that have been widely used in China; this is due to their relatively low operation cost, and so it is recommended to apply ATR-FT-IR methods as QC tools for pharmaceutical companies, especially for developing countries. Implementation of IR methods for QC of traditional Chinese medicines has been described and reviewed by Sun et al. [37] . QC methods for herbal drugs have been published and reviewed using FT-IR and Raman spectroscopy [38, 39] . Different grades of Panax notoginseng powders can be directly differentiated by using FT-IR and 2D FT-IR [40] . A combination of ATR-FTIR micro-spectroscopy imaging can be applied directly for identifying complex mixtures of powdered herbal drugs [41] .
Chemical constituents of herbs and herb materials are very complex and that is why the evaluation of the chemical profiles (chromatography and spectroscopy) should be performed in combination with MVA i.e. PCA, HCA, PLS-DA, SIMCA etc. It seemed very difficult or impossible to evaluate chromatographic-or spectroscopic-profiles of samples without any combination with MVA. Chromatographic and spectroscopy profiling/fingerprinting that is mostly combined with MVA have been widely used for the evaluation or QC of herb/plant materials; some good examples have been described in previous publications [2, 19, 34, [42] [43] [44] . Some
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Natural Product Communications Vol. 13 (12) 2018 1601 factors that could affect the chemical profiles are the quality of samples, method of drying, method of extraction, equipment, analytical method and its validation. Identical chemical profiles of samples will be shown by a tight clustering in the score plot of the PCA. For QC purposes, the identity of the (incoming) herb raw materials or extract generally can be evaluated by using a pattern recognition technique i.e. soft independent modeling of class analogy (SIMCA) [23, 45] ; other methods e.g. linear discriminant analysis (LDA) or support vector machines classification (SVMC) can be applied [46, 47] . Quantitative determination of certain herbs in the drug preparations can be performed by using PLS regression; for example that given by Wang et al. [36] . Quantitative determination of components of the mixture of herbal medicines can also be performed by using the ratio of two specific peaks of FT-IR [37] . The processing of chemical profiles (metabolite profiling or metabolomics) data (e.g. LC/GC-MS, NMR) can be completed using a wide range of free on-line software [48] ; our experience showed that sophisticated LC-HR MS/MS equipment generally has already been completed with MVA software. Similarity analysis of chromatograms or FT-IR spectra of samples and BRM can also be performed by calculating their correlation coefficient (r) and congruence (c) values; values of r and c close to one means that the chemical profiles are identical; the threshold value of r should be > 0.990 [49, 50] . Identical chemical profiles of two samples indicate that the samples have identical qualitative and quantitative biochemicals, and so the two samples are phytoequivalent to each other; this means that the two samples will have equivalent bioactivities or toxicities. AOAC [12] described the validation of a botanical identification method (BIM). For validating the BIM for certain applications, specified inferior test materials (SITM) and specified superior test materials (SSTM) should be prepared and determined. SITM was a botanical (herb) mixture of materials that has the maximum concentration of target material (herb) that is considered unacceptable (negative result) as specified by its standard method requirements (SMPR), whilst SSTM was a mixture of herbs which have minimum concentrations of target herb that is considered acceptable (positive result). For preparing SITM and SSTM the author recommends using official BRM (if any), or herb that was cultivated in a defined location and has been scientifically identified.According to USP 41 <1039> [51] any chemical method that is combined with chemometrics analysis should demonstrate the capability to identify correctly or classify the herb samples, so receiver operating characteristic (ROC) curves should be constructed. ROC curves can be constructed by using values of true-positive rate (TPR) versus false-positive rate over a range decision threshold; a good identification method should generate an ROC curve with the area under the curve (AUC) close to one. Samples with 0% and 100% of SSTM can be used to select the BIM of certain herbs based on the ROC.The validity of a BIM method that is determined by a ROC curve should be validated using a probability of identification (POI) method according to AOAC Appendix K [12] .The ideal goalof a validation method is the discrimination of SSTM and SITM with a specified degree of confidence (e.g. p = 0.05); 1-POI at 0% of SSTM was a falsepositive fraction, whilst 1-POI at 100% of SSTM was a falsenegative fraction. Acceptance criteria according to this guidance of AOAC were: 1-side (95%) confidence interval (CI) at 0% SSTM should be below 10% and 100% should be above 90%; CI can be calculated according to the previous publication [52] . Detailed discussion of this validation method was already described and discussed by the guideline of the AOAC [12] .
A chemical profiling method (chromatography and spectroscopy) combined with MVA can also be applied as a QC tool for either evaluation or standardization of IPC-and FP-samples during production. For validating the method, laboratory-made preparations (LM) of IPC and FP should be prepared as training sets for building the SIMCA models for qualitative analysis. Quantitative estimation of certain herbs in IPC-and FP-samples can be performed by using PLS regression. The validity of the models can be tested using cross-validation, or by other LM preparations or herb/food materials [53] [54] [55] . Evaluations of chemical profile of samples and LM preparations for each stage of production can also be performed by using a similarity method (using r or c),as described above. Due to the relatively fast analysis-time and lowoperation-cost, the application of direct ATR-FT-IR combination with chemometric evaluation is strongly recommended as the QC tool for herbs or extracts in herbal drug preparations. A combination of second derivative and two-dimensional (2D)-FT-IR with MVA can be applied if 1D-ATR-FT-IR failed to show a good ROC. For QC purposes using chemical profiling methods, the availability of BRM, standardized extracts and standardized LM sample of each stage of production are needed. Standardization of extracts or LM sample, which will be used for QC, should be performed by using more sophisticated equipment such as LC/GC-MS (MS).
DNA profiling as identification method for herbs:
Identification of botanical samples or herbs using DNA-based profiling has been described by USP 41 <563> [27] . This method was applied to distinguish between closely or morphologically similar species; these included DNA bar coding and DNA (Sanger). DNA bar coding is a particular DNA sequence-based identification method that uses a short sequence of specific nuclear plastid DNA loci for identification of plant species. Botanical identification using DNA (Sanger) sequencing methods includes marker selection, DNA extraction, polymerase chain reaction (PCR) primers and amplification, DNA sequencing and comparison with reference materials. Detailed discussions that described the applications of DNA profiling including DNA bar coding, and their limitations for identification of herbs, were reported inprevious publications [56] [57] [58] . Recently Osathanunkul et al. [59] reported the application of the DNA bar code method for identifying the herb Tinospora sp in commercial herbal supplement preparations (tablet and capsule).
Due to many external factors that can affect the (secondary) metabolites content of a plant both qualitatively and quantitatively, a QC tool using DNA profiling must be completed using chemical methods; it is well known that the bioactivity-and toxicity-profiles of herbal products are dependent on their biochemical content qualitatively and quantitatively. For this reason, application of DNA profiling alone as a QC tool is not recommended; plants that have identical DNA profiles might have different chemical profiles. Combination of DNA-and metabolite-profiling studies will be very useful for determining whether the difference in metabolite contents of herbs or plants was due to the difference in strains of the plant species or to some external factors.
Marker and its application as the QC tool of herbal medicines:
USP 41 <563> [27] described markers as active, analytical and negative, whilst EMA [5] described active and analytical markers only. Markers could also be categorized and summarized as follows: therapeutic components, toxic components, bioactive components, main components, synergistic components, characteristic components and correlative components. However, due to many external factors that can influence the qualitative and quantitative chemical profile of plants, the application of simple marker definition as a QC tool unfortunately cannot be directly Indrayanto applied [1, 60] . To overcome this problem Benssousan et al. [1] proposed a new term i.e. Herbal Chemical Marker Ranking System (Herb MaRS). In this new system,chemical markers were ranked in various categories i.e. x, 0, 1, 2, 3, 4 and 5; this ranking was based on direct observations of therapeutic or toxic effects that are detectable and measurable for the marker(s) in herb-preparations; only Herb MaRS that has a ranking of 3-5 can be applied as a QC tool. Recently, Rivera-Mondragôn et al. [61] reported some chemical markers that can be applied as QC tools for the genus Cecropia based on the categories of Herbs MaRS. WHO guidelines [62] describe a method for selection of the marker(s) as the QC tool; this guideline describes a marker as a constituent with known therapeutic and or pharmacological activity, and markers should be detectable and quantifiable, and so a marker must occur in sufficient quantity in the herb drugs. If a marker is used for BIM, it must be specific for one plant or certain plant species and genera. Liu et al. [63] and Yang et al. [64] proposed the term Q-marker that can be summarized as follows: (1) a marker is a chemical compound that exists in herbs in traceable quantity; (2) markers can be qualitatively and quantitatively determined; (3) markers should be associated with special bioactivity; (4) the related effect and pharmacokinetics data of the marker are known; and (5) markers should be related to traditional use. It can be assumed that WHO's definition of a selected marker, and the term Q-marker showed almost the same descriptions as a Herb MaRS ranked 3-5. For simplification, all these categories of a marker will be described in this present review as quality active marker (QA-marker). If for certain herbs the QAmarker is not yet determined, a combination of chemical profiles, bioactivity/clinical-profiles and PLS-DA can be performed for determining the QA-marker. Unfortunately, only few publications have described the QA-marker for certain herbs that appear nowadays (2015-2018); and most of these recent publications did not mention the limit of specification range (λ) of the QA-marker for specific therapeutic application. For QC purposes, all commercial drug preparations must have a detailed analytical target profile (ATP), in which the target concentration τ ± λ of the active pharmaceutical ingredient (API) must be described. If this limit specification range is not yet available the pharmaceutical industry must self-determine the limit specification range for each QAmarker in all their commercial herbal products.
Constituents of interest or identity markers (for each of the herb's monographs) have been described by some guidelines [14] [15] [16] . Our experience showed that it was not easy to select specific chemical marker(s) for a certain herb or plant; the compound of interest might not be detected in the described plant, or it could also be detected in many other plants [1, 60] . Therefore, it is not recommended to apply this identity marker or compound of interest as sole BIM for an individual commercial herb(s) or plant material(s), or in their mixtures. For validation of the BIM by using a chemical marker, SITM and SSTM must be prepared (section 3), and this could be very difficult, because the concentrations of marker(s) in plants can be affected by many external factors [1] .
It is well known that chemical constituents of herbal drug preparations are very complex, so the method of choice for the QC tool must be a chromatographic one (HP/TLC, UPLC, HPLC, GC); all methods should be validated first, before being applied for routine application. The most important validation parameter is the selectivity or specificity of the method; identity and purity of all target peaks in samples must be evaluated and verified using either a DAD or MS detector; the Rs-value of the target peak to the nearest peak should be >1. 75 . If multiple reactions monitoring (MRM) by LC-MS/MS can be performed, there is no need to check the Rs-value of the target peak, if the chemical structures of the target marker(s) are known. Important recent developments in chromatographic validation methods for the compound/marker approach have been reviewed and discussed recently [23] . A brief summary of the important developments is presented in Table 1 . AOAC published Standard Method Performance Requirements (SMPRs) for analyzing certain compounds (markers) in certain preparations. This SMPR described method performance requirements for certain compounds (recovery, repeatability, reproducibility, detection limit), but unfortunately a detailed analytical method was not described. For example, AOAC SMPR 2017.003 [65] described SMPR of proanthocyanidin in cranberry fruit, juice, beverage, dried cranberry, cranberry sauce, ingredients and dietary supplement formulations. Monographs of the USP herbal medicines compendium [14] and other guidelines [15] [16] [17] [18] generally describe the method of analysis and the minimum concentration criteria of a certain or group of marker(s) in the specific herbal preparations. The described method of analysis could be applied for the specific described raw materials or preparations, but unfortunately cannot be used for analyzing the marker(s) in other herb preparations or mixed herbal drug preparations. A valid method of analysis of marker(s) must be developed for each of the specific herbal drug preparations.
Recently Langer et al. [66] stated that the criteria of minimum concentration of certain marker(s), or a group of constituents/markers in certain herbs, described by some guidelines, cannot be correlated directly with its quality or efficacy, but sometimes these criteria can be correlated only with the quality of certain herbs. For correlating the concentrations of certain marker(s) in herb preparations to its efficacy and safety, quantification of QAmarker(s) should be carried out to determine whether its concentration in herb preparations is included in its limit specification range.
Due to the limited amount and relatively high price of many authentic standard markers, quantitative determination of marker(s) in herbal drugs as a QC tool can sometimes be very difficult. Ning et al. [67] , Xu et al. [68] and Zhu et al. [69] proposed quantitative analysis of multi-components using a single marker only (QAMS), or single reference standard for determination of multi-components (SSDMC). This method does not need to have all authentic standards for the quantification of many markers in herbal drugs. Those authors proposed a method that used a single marker only as standard; concentration calculation for other marker(s) can be performed using a correction or conversion factor (F). where s = standard marker, x = marker x, A = respond detector or peak area; C = concentration, i = concentration levels, n = number of concentration levels.
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According to EMA [70] , for performing a single point calibration (equation 3), the concentrations of Cx must be within ± 30% of Cs. A validation method for QAMS or SSDMC can be performed by using a standard addition method, as described in our previous review [23] , or by comparing the results of analysis using a QAMS/SSDMC method to results analysis that used specific standards for each marker; detailed validation methods for comparing two procedures have already been described in theUSP 41 <1010> [26] .
The results (R) of analysis of any QA-marker(s) in herbal drug preparations, or the results of recovery evaluations should be included in the pre-determined specification range (label claim/target concentration ± λ) that was described in the ATP; R should be calculated by equation 4 instead of equation 5.
. (5) CI is confidence interval, PI is prediction interval and TI is tolerance interval; detailed equations are described in the USP 41 <1010> and <1210 [26, 71] . For QC purposes, it is recommended to apply TI instead of CI or PI [23] .
Recently Zhao et al. [9] proposed certain polysaccharides as QAmarkers for a QC tool for a Chinese traditional medicine (TCM), due to a long history of the application of a water-decoction for TCM. Shi et al. [66] proposed effective combinatorial markers (ECM), whilst Guo et al. [10] proposed an effective compounds combination (EEC) instead of certain markers as a holistic QC tool for herbal medicine. EMC or EEC was determined using an (animal) bioactivities model. Lee et al. [73] determined 14 markers simultaneously (Herb MaRS ranked >3) from Chinese medicine formulations containing a seven herbs mixture; the same concept using many markers as a QC tool was developed by Yang et al. (74) ; these markers were named bioactive chemical markers (BMC). According to the description of EMC, EEC and BMC, these categories of marker could also be defined as QA-marker(s). Analyses of some specific QA-marker(s) from herbal drug preparations might be used to replace conventional chemical profiling, but further work is needed to confirm this. In conclusion, quantification of certain marker(s) as a QC tool for herbal drug preparations could be well applied and correlated to its efficacy if the marker(s) is a QA-marker. As a QC tool, the specification limit of each QA-marker (label claim or target concentration ± λ) should be determined for every marketed herbal medicine for specific therapeutic application.
Analysis of chemicals and toxic-compounds in herbal drugs:
In order to ensure the safety of herbal drug preparations, concentrations of endogenous toxic metabolites, heavy metals, residual pesticides, mycotoxin, harmful organic additives, pollutants, chemical drugs and antibiotics in herbal drugs or extracts should be below the maximum permitted level (MPL) or maximum residual limits (MRL); this means that the method used must have a sample detection limit (DL) below its MPL. The amount of endogenous toxic compounds should be not more than 1.5 µg/day for carcinogenic and genotoxic compounds [1] .
According to guideline VICH GL 49 [75] a sample's detection limit must be determined in two steps i.e. first by determination of the instrumental DL, and then a sample's DL, as described by equations 6 and 7. It is recommended to determine a sample's DL for each different matrix. Instrumental QL (quantification limit) was estimated by 3 Dl. An amount of standard toxic compound at a concentration of instrumental QL was spiked to the matrix, then the sample was analyzed using the proposed method, and the SD was calculated (n= 7 replications). Sample DL = t. s........... (6) Sample QL = 3. DL....... (7) where t is one-tailed (p = 99%, n-1), and s is the SD of the results of analysis of the spiked sample,
It is recommended to apply the method of the USP 41 <1210> or VICH GL49 [71, 75] for determining the instrumental DL. For this, a linear regression curve that uses relatively low concentrations of the target toxic compounds in a certain matrix should be constructed. This method of DL determination was identical to the that described previously by Funk et al. [76] ; in this case,DL = Test value Xp/Xa (p = 0.05), and QL = 3 DL. Detailed discussion regarding this Xp/Xa was provided by previous publications [23, 76] . Sample DL that has been calculated by equation 6 must be verified according to the Eurachem Guide [77] . For this verification, a cut-off value must be determined with a falsenegative not more than 5%, as a general acceptance criterion.
Values of sample DL must be lower than the cut-off value, and the cut-off value must be lower than the MPL. Detailed discussion is presented in a review by the author [23] .
General methods for the determination of toxic compounds and their MPL in herbal drugs, such as heavy metals, pesticides, and toxins have been described by some guidelines [3, [12] [13] [14] .Official methods for the determination of aflatoxins and residual pesticides have also been described [13, 25] ,whilst methods for determination of As, Cd, Pb, Hg total, methyl Hg and other toxic metals are described by the guidelines of USP <233> [78] and WHO [13] . EMA [64] described in detail a method validation procedure for pesticide residual analysis. For analysis of chemical drugs in marketing dietary supplements, official methods from the USP 41 <2251> can be applied [79] ; these methods can be used for detecting chemical drug(s) in herbal medicines. Recently, Thermo Fischer Scientific described an on-line calculation method i.e. "J value Calculator" for calculating the MPL of certain metals in the (herbal) drug preparations [80] .
Determination of non-specific parameters and foreign matters:
According to the American Herbal Product Association [81] , WHO [13] , and USP <561> [25] herbal products should be free of foreign matter i.e. parts of herbs other than those named, soil, stones, sand, dust, glass, plastic, metals and foreign inorganic matter. Herbals should be examined for the absence of visible signs of contamination by mold, insects and other animal contamination or excreta; it should be free of abnormal odor, discoloration, slime or signs of deterioration. Non-specific parameters that should be determined are: ash (total ash, acid-insoluble ash and water-soluble ash), extractable matter (water and ethanol), water and volatile matter, volatile oils, bitterness value, hemolytic activity, swelling index, foaming index, tannin total, crude fibers and starch content; methods of determination have already been described in detail [13, 25] . For botanical extracts, non-specific parameters that should be determined are residue on evaporation, residual solvents and alcohol [82] . It seems it is difficult to correlate directly the nonspecific parameters to therapeutic-activity, toxicity and chemical profiles of the herbal drug preparations. These non-specific parameters might be applied for thesimple-standardization of the herbal medicines in which their QA-marker(s) and/or chemical profiles are not yet determined.
Conclusions and recommendations:
For producing good quality herbal drug preparations, botanicals and phyto-pharmaceuticals, all incoming raw plant materials, extracts and excipients must be strictly tested. It means that a completedQC must be performed i.e. evaluating the identity of raw materials and their chemical profiles, quantification of the QA-marker(s) (if any), confirming all toxic compounds must be < MPL, and determining other selected nonspecific parameters; all those measured data of the incoming materials must fulfill the pre-determined specification range or acceptance criteria. Evaluation of the possible contamination of toxic compounds for IP samples is not needed. FP and KP samples should be evaluated according to the parameters described by their certificates of analysis and/or labels. The QC laboratory of the pharmaceutical company should be able to assure that the contents of the herbal product are exactly as printed on the label (Figure 1 ).
If a QA-marker in a certain herb is already well specified, there is no need for chemical profiling for this herb. In this case, the result of quantitative analysis of the QA-marker in the herb must be included in the pre-determined specification range of the ATP (target concentration/label claim ± λ). Further work is needed to determine the best marker categories (Q-marker, Herbs MaRS, ECM, EEC, or BMC) that can replace the chemical profiling. If a QA-marker is not yet well specified for a certain herb, chemical profiling should be performed as the main QC tool.If the limit specification range for a certain QA-marker is not yet officially available, the pharmaceutical industry should undertake research to determine it before commercialization of the product. Criteria of minimum concentrations of certain markers, as described in some guidance, unfortunately cannot be applied as a QC tool [66] .
FT-IR methods (ATR, 2D, Imaging) combined with MVA are recommended as QC tools for qualitative and/or quantitative analysis of individual herbs or extracts and in drug preparations. These methods are relatively cheap, fast and accurate compared with the chromatographic methods. For application of FT-IR methods, authentic BRM, standardized QC samples of IP and FP must be available; SITM and SSTM for every method must be first determined and validated. The author recommends FT-IR methods as a QC tool for pharmaceutical companies in developing countries.
Application of a DNA method only as a QC tool is not recommended due to the lack of specificity; DNA methods are recommended for detection of species substitution or falsification [83] . Constituents of interest or identity markers are not recommended to be applied as BIM of any herbs; this is also due to the lack of specificity.
To gain reliable results of any analysis performed by a QC laboratory, all methods used must be validated according to the latest guidance. In addition, internal quality control (IC) as described by Eurachem [77] must be carried out for each series of measurements by using QC samples. If the results of QC samples cannot fulfill the acceptance criteria, the results of analysis of the whole series of the measurements on that day must be removed or must be re-analyzed, and a partial or full re-validation of the method considered.
